Mraz Amerine & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
12,368
+63
+0.5% +$5.06K 0.15% 88
2026
Q1
$1.03M Sell
12,305
-85
-0.7% -$6.4K 0.15% 87
2025
Q4
$831K Hold
12,390
0.12% 95
2025
Q3
$838K Hold
12,390
0.13% 98
2025
Q2
$923K Sell
12,390
-66
-0.5% -$4.4K 0.15% 92
2025
Q1
$761K Buy
12,456
+1
+0% +$62 0.13% 93
2024
Q4
$709K Buy
12,455
+1
+0% +$59 0.13% 95
2024
Q3
$732K Buy
12,454
+2
+0% +$109 0.13% 94
2024
Q2
$672K Buy
12,452
+1
+0% +$55 0.14% 97
2024
Q1
$718K Buy
12,451
+1
+0% +$52 0.14% 96
2023
Q4
$597K Sell
12,450
-198
-2% -$9.44K 0.13% 102
2023
Q3
$647K Buy
12,648
+1
+0% +$53 0.15% 94
2023
Q2
$725K Buy
12,647
+1
+0% +$58 0.17% 89
2023
Q1
$763K Buy
12,646
+1
+0% +$61 0.19% 87
2022
Q4
$743K Buy
12,645
+1
+0% +$63 0.18% 85
2022
Q3
$723K Buy
12,644
+1
+0% +$58 0.19% 78
2022
Q2
$684K Sell
12,643
-9
-0.1% -$522 0.18% 82
2022
Q1
$727K Buy
12,652
+1
+0% +$51 0.17% 86
2021
Q4
$598K Buy
12,651
+1
+0% +$46 0.15% 88
2021
Q3
$532K Sell
12,650
-98
-0.8% -$4.24K 0.15% 96
2021
Q2
$565K Sell
12,748
-65
-0.5% -$3K 0.15% 93
2021
Q1
$597K Buy
12,813
+1
+0% +$44 0.17% 84
2020
Q4
$496K Buy
12,812
+1
+0% +$36 0.16% 87
2020
Q3
$369K Buy
12,811
+2
+0% +$56 0.14% 86
2020
Q2
$343K Buy
12,809
+2
+0% +$52 0.13% 89
2020
Q1
$301K Hold
12,807
0.12% 90
2019
Q4
$379K Hold
12,807
0.11% 105
2019
Q3
$359K Buy
+12,807
New +$370K 0.11% 101

Other funds holding CTVA

Mraz Amerine & Associates's CTVA Position: Q2 2026 in Review

Mraz Amerine & Associates increased its Corteva (CTVA) stake by 0.51% in Q2 2026, buying an estimated $5.06K and bringing the position to 12,368 shares worth $1.05M. The position accounts for 0.15% of the portfolio, ranked #88.

Mraz Amerine & Associates first reported a position in CTVA in Q3 2019 and has held it in 28 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Mraz Amerine & Associates held 12,368 shares of Corteva worth $1.05M as of Q2 2026.
  • Mraz Amerine & Associates bought 63 Corteva shares in Q2 2026, an estimated $5.06K.
  • Corteva made up 0.15% of Mraz Amerine & Associates's portfolio in Q2 2026, its #88 holding.
  • Mraz Amerine & Associates first reported a position in Corteva in Q3 2019 and has held it in 28 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.